CELG has $68B mkt cap and a $166 stock, and it's EPS estimated at $7.30 for 2014. QCOR has $3B mkt cap and is a $53 stock with estimated $7.50-$8+ eps for 2014. Think about that....
Note: I'm not saying CELG is a short, but I am more excited about QCOR at $53 than when it was at $5 stock just focusing on Infantile Spasm. Importantly, given rev and earnings growth (along w/ lots of new indications), one should know that mgmt is focused on the next 3-5 years and building a $20B mkt cap company (recall the 2 new board members who have done this before). Imho, QCOR is a $200 stock posing as a $53 stock.
Btw, for all the guys out there who want to focus on the "noise" - go ahead. Just know that the same "noise" is a badge of honor - just look at what happened to these companies based on "single product, nothing proprietary, investigations, yada, yada, yada" - Tesla at $25, GMCR at $20, HLF, QIHU, and they all went up 3 to 4x AFTER the shorts bashed.
I agree. Based on past performance, QCOR is disciplined, clearly moving to add value to the enterprise with every step. Are they doing everything we would like them to do, no. But this does not take away from the proven performance over the last few years. QCOR has very good options under consideration. Build business with what they own. Build business with more acquisitions. Build share holder value with buy back.
On the short side, their endgame is lower price to eliminate own short position. The fact that the attack is organized and relentless points to how big the need to lower price to eliminate short position is at this time. Analyze their thesis and you won't see much in terms of facts percolating to the top.
Sentiment: Strong Buy